Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2000
12/13/2000CN1276370A Process for preparing anticancer compound, and intermediate
12/13/2000CN1276239A Anticancer pill and its preparing process
12/13/2000CN1276226A Plaster for treating cancer and tumor
12/13/2000CN1059465C Method for diagnosing disorder by determining expression of GAGE tumor rejection antigen precursors
12/13/2000CN1059333C Chinese patent drug for various cancers and tumors
12/12/2000US6160184 A chemical intermediate for forming a drug treating cancer
12/12/2000US6160135 Taxoids, preparation thereof and pharmaceutical compositions containing same
12/12/2000US6160106 Nucleotide sequences which code polypeptides which prevent gene expression; for use as diagnostic screening tools in the detection and treatment of cancer; anticarcinogenic agents
12/12/2000US6160099 Anti-human αv β3 and αv β5 antibodies
12/12/2000US6160088 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins
12/12/2000US6160015 Administering to mammal a farnesyl protein transferase inhibitor
12/12/2000US6160004 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
12/12/2000US6159995 Substituted diaminocarboxylic acids
12/12/2000US6159984 Farnesyl protein transferase inhibitors
12/12/2000US6159978 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/12/2000US6159964 Vitronectin receptor antagonists
12/12/2000US6159960 Steroid sulphatase inhibitors
12/12/2000US6159957 Antitumor agents
12/12/2000US6159937 Immunomodulators
12/12/2000US6159734 Nucleotide sequences which prevent or reduce transcription of human gene; for the treatment of non-insulin dependent diabetes, cardiovascular disorders and gastrointestinal disorders; antiinflammatory agents; anticarcinogenic agents
12/12/2000US6159704 Phosphatase modulator
12/12/2000US6159701 Imaging tumor cells in vivo by obtaining sample of monocytes, macrophages, or splenocytes; priming the cells; labeling with radiolabelled a1 adenosine receptor agonist which induces cytotoxicity in the cells; administering to patient
12/12/2000US6159697 Antisense modulation of Smad7 expression
12/12/2000US6159694 Antisense modulation of stat3 expression
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/12/2000US6159443 X-ray guided drug delivery
12/12/2000US6159143 Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
12/12/2000CA2167397C Indoles
12/12/2000CA2160881C 10,11-methanodibenzosuberane derivatives used as chemosensitizing agents
12/12/2000CA2046997C Liposomal products
12/12/2000CA1341152C Receptor protein for human b cell stimulatory factor-2
12/07/2000WO2000074073A1 Sterile radioactive seeds
12/07/2000WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor
12/07/2000WO2000073764A2 Composition and methods for the therapeutic use of an atonal-associated sequence
12/07/2000WO2000073478A2 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
12/07/2000WO2000073469A2 Protein kinases
12/07/2000WO2000073459A1 Four-helical bundle protein zsig81
12/07/2000WO2000073456A1 A VARIANT OF C6 β-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY
12/07/2000WO2000073451A1 Mammalian receptor proteins; related reagents and methods
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3)
12/07/2000WO2000073443A1 Lipid metabolism transcription factor
12/07/2000WO2000073441A1 GENE Any-RF, DORMANCY REGULATORY SUBSTANCE, PROCESS FOR PRODUCING THE SAME AND CELL REGULATOR FOR VITAL CELLS
12/07/2000WO2000073438A1 Tumor-associated antigen (c42)
12/07/2000WO2000073433A1 Screening method for peptides
12/07/2000WO2000073415A2 A method for the transfer of antigens to dendritic cells
12/07/2000WO2000073349A1 Dr4 antibodies and uses thereof
12/07/2000WO2000073348A2 Methods and compositions for inhibiting neoplastic cell growth
12/07/2000WO2000073346A1 Immunoconjugates having high binding affinity
12/07/2000WO2000073344A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
12/07/2000WO2000073340A1 C-cam as an angiogenesis inhibitor
12/07/2000WO2000073338A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
12/07/2000WO2000073334A2 Human sorting nexins
12/07/2000WO2000073327A1 Chemokine receptor ccr3 antagonists
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000073321A1 Human tumor necrosis factor receptor tr10
12/07/2000WO2000073307A2 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
12/07/2000WO2000073295A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
12/07/2000WO2000073294A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
12/07/2000WO2000073293A1 Semi-synthesis of paclitaxel using dialkyldichlorosilanes
12/07/2000WO2000073281A1 Thymine derivatives that possess antiviral and antitumoral effects
12/07/2000WO2000073276A2 Carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
12/07/2000WO2000073275A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000WO2000073266A1 Novel antioxidants, preparation methods and uses
12/07/2000WO2000073264A1 Cell proliferation inhibitors
12/07/2000WO2000073263A1 Cytofectin dimers and methods of use thereof
12/07/2000WO2000073253A1 NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-α MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS
12/07/2000WO2000072881A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072864A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000WO2000072861A1 Pharmaceutical preparations of bioactive substances extracted from natural sources
12/07/2000WO2000072849A1 Novel epidermal growth factor receptor-binding compounds for positron emission tomography
12/07/2000WO2000072815A1 Indole derivatives
12/07/2000WO2000072801A2 Alpha v integrin receptor antagonists
12/07/2000WO2000072679A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000WO2000072666A2 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE
12/07/2000WO2000050565A3 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
12/07/2000WO2000049937A3 Trpm-2 antisense therapy
12/07/2000WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
12/07/2000WO2000045849A3 Use of cationic lipids to generate anti-tumor immunity
12/07/2000WO2000044392A3 Identification of specific differentially expressed mycobacterial antigens
12/07/2000WO2000037141A9 Combination chemotherapy
12/07/2000WO2000031247A3 Recombinant methods and materials for producing epothilone and epothilone derivatives
12/07/2000DE19925143A1 Neue liposomale Vektorkomplexe und deren Verwendung für die Gentherapie New liposomal vector complexes and their use for gene therapy
12/07/2000DE19924892A1 Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their preparation and use as endothelin receptor antagonists
12/07/2000DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms
12/07/2000CA2414214A1 Four-helical bundle protein zsig81
12/07/2000CA2414094A1 Pharmaceutical preparations of bioactive substances extracted from natural sources
12/07/2000CA2383244A1 Protein kinases
12/07/2000CA2376133A1 Tumor-associated antigen (c42)
12/07/2000CA2376116A1 Promotion or inhibition of angiogenesis and cardiovascularization
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375827A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000CA2375826A1 Novel epidermal growth factor receptor-binding compounds for positron emission tomography
12/07/2000CA2375666A1 Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
12/07/2000CA2375657A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000CA2375349A1 A method for the transfer of antigens to dendritic cells
12/07/2000CA2375348A1 Novel antioxidants, preparation methods and uses
12/07/2000CA2375253A1 Semi-synthesis of paclitaxel using dialkyldichlorosilanes
1 ... 1864 1865 1866 1867 1868 1869 1870 1871 1872 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 1883 1884 ... 2211